|
CN112143796A
|
|
CARD16 as molecular marker for diagnosis and identification of tuberculosis
|
|
CN112143797A
|
|
HIST1H2BC applied to differential diagnosis of active tuberculosis
|
|
CN112143793A
|
|
Application of ODF3B as tuberculosis diagnosis molecular marker
|
|
CN112143800A
|
|
Application of molecular marker APOL3 in diagnosis of tuberculosis
|
|
CN112143792A
|
|
Application of RNF181 as tuberculosis diagnosis molecular marker
|
|
CN112143794A
|
|
Application of NDUFB1 as tuberculosis diagnosis molecular marker
|
|
CN112143799A
|
|
Application of C5orf56 in identification and diagnosis of active tuberculosis
|
|
CN112143798A
|
|
Application of NT5C3A as tuberculosis diagnosis molecular marker
|
|
CN112143791A
|
|
Application of SECTM1 as tuberculosis diagnosis molecular marker
|
|
CN112143795A
|
|
Application of CLEC2B gene as tuberculosis differential diagnosis
|
|
CN112080556A
|
|
Method for performing multiple rapid sequencing on gonococcus drug-resistant gene
|
|
CN112029844A
|
|
Use of intestinal microorganisms for diagnosing dystonia
|
|
CN111662959A
|
|
High-throughput rapid detection method for fungi
|
|
CN111704661A
|
|
Application of schistosoma japonicum schistosomulum high-expression gene or coding protein thereof
|
|
CN111728973A
|
|
Medicine for resisting novel coronavirus SARS-CoV-2 and its application
|
|
CN111643656A
|
|
Broad-spectrum coronavirus membrane fusion inhibitor and application thereof in resisting AIDS virus
|
|
CN111394513A
|
|
Fluorescent quantitative PCR detection method for novel coronavirus SARS-CoV-2 and application thereof
|
|
CN111349720A
|
|
Nucleic acid reagent, kit, system and method for detecting respiratory tract infection virus
|
|
CN111440859A
|
|
Biomarker for human respiratory syncytial virus infection and application
|
|
CN111303279A
|
|
Single-domain antibody for novel coronavirus and application thereof
|
